Resources

Knowledge Center
Filter
Blogs
Case Studies
Data
Factsheets
Govt. Strategies, Plans, and Documents
High-Impact Practices
Infographics
Meeting Documents
Newsletters
Opportunities
Presentations
Publications
Q&A
Remarks
Toolkits
Videos and Webinars
Website and Portals
Advocacy & Awareness
Beyond 2020
Contraceptive Security
ECHO Study
Financing
Innovation
Policy and Enabling Environment
Rights
Service Delivery & Quality
Young People
Commitment Maker
Country
Commitment Maker
Country
Date: 01/31/2017
Source: Family Planning High Impact Practices
Type: High-Impact Practices
Economic empowerment is the ability to make and act on decisions that involve the control over and allocation of financial resources. Women’s influence over financial decisions is associated with increased use of preventive health services by children and women, including use of modern contraceptive methods. Thus, interventions that aim to increase the economic power of women and girls may...
Date: 01/24/2017
Source: PATH
Type: Publications
Through an initiative coordinated by PATH, Sayana Press (DMPA-SC in Uniject) was made available from family planning providers in Burkina Faso, Niger, Senegal, and Uganda beginning in 2014. During the two years of pilot introductions, PATH gathered a rich repository of results that point to the product’s potential to broaden the contraceptive method mix, facilitate the provision of injectables by...
Date: 11/18/2016
Source: PATH
Type: Newsletters
Self-injection of Sayana Press holds great promise for helping women overcome access barriers and increase their ability to manage their health. Results from a PATH-Ministry of Health study on self-injection in Uganda, newly available online through the journal Contraception, indicate that self-injection is feasible and highly acceptable among most study participants in Uganda. In the study, 380...
Date: 11/18/2016
Source: PATH
Type: Newsletters
As access to Sayana® Press (subcutaneous depot medroxyprogesterone acetate, or DMPA-SC in Uniject™) expands globally, PATH has monitored product consumption in four pilot introduction countries: Burkina Faso, Niger, Senegal, and Uganda. As the introduction phase draws to a close and all four countries move toward scale-up, they are transitioning Sayana Press consumption data collection into...
Date: 11/16/2016
Source: PATH
Type: Case Studies
Self-injection of the contraceptive Sayana® Press is both feasible and highly acceptable among women participating in the first such research study conducted in sub-Saharan Africa, according to results published online by the journal Contraception. Sayana Press is an all-in-one injectable contraceptive that puts control of women's health in their hands. It is a subcutaneous formulation of the...
Can we help you find something?
Advocacy & Awareness
Beyond 2020
Contraceptive Security
ECHO Study
Financing
Innovation
Policy and Enabling Environment
Rights
Service Delivery & Quality
Young People
Commitment Maker
Country
Commitment Maker
Country